Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study.
Novi G, Bovis F, Sciolla C, Frau J, Minetti M, Napoli F, Vianello M, Greco G, Sechi E, Bellomo A, Garelli P, Spiezia AL, Fantozzi R, Schirò G, Ghezzi L, Zecca C, Signoriello E, Brambilla L, Lucchini M, Bonavita S, Schiavetti I, Malentacchi M, Cocco E, Franceschini A, Mataluni G, Gastaldi M, Rolando A, Solla P, Cellerino M, Abbadessa G, Lanzillo R, Di Sapio A, Uccelli A, Sormani MP.
Novi G, et al. Among authors: solla p.
CNS Drugs. 2025 Jul;39(7):693-705. doi: 10.1007/s40263-025-01191-7. Epub 2025 May 29.
CNS Drugs. 2025.
PMID: 40442445